Probiotics in Critically Ill Patients: An Umbrella Review.
Critical illness
Intensive care units
Probiotics
Systematic review
Umbrella review
Journal
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine
ISSN: 0972-5229
Titre abrégé: Indian J Crit Care Med
Pays: India
ID NLM: 101208863
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
entrez:
6
5
2022
pubmed:
7
5
2022
medline:
7
5
2022
Statut:
ppublish
Résumé
Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host. Because of the wide usage of antibiotics, acute changes in diet, and the stress of illness, critically ill patients' homeostasis of the gut microbiome can be disrupted during intensive care unit (ICU) confinement; probiotics are suggested as a beneficial intervention in critically ill patients. We tried to give an overview of the effects of probiotic supplements in critically ill patients based on published systematic reviews (SRs) and meta-analyses (MAs). A systematic search was performed in four databases as well as hand searching. The results were independently screened in two title/abstracts and full-text stages. Any reported outcomes in each study were extracted, using a data extraction table. A wide range of outcomes of using probiotic supplements in critically ill patients have been reported in 20 included studies. Based on the current knowledge, we can say that probiotics may reduce the rate of ventilator-associated pneumonia, nosocomial pneumonia, the overall infection rate, duration of mechanical ventilation, and antibiotic use in critically ill patients, but there is not a significant association between using the probiotics and mortality, length of hospitalization, and incidence of diarrhea. Despite the various beneficial effects of probiotics in critically ill patients, there is not yet much evidence supporting the routine use of these supplements and further well-designed multicenter trials are needed to provide "evidence-based" recommendations. Naseri A, Seyedi-Sahebari S, Mahmoodpoor A, Sanaie S. Probiotics in Critically Ill Patients: An Umbrella Review. Indian J Crit Care Med 2022;26(3):339-360.
Identifiants
pubmed: 35519905
doi: 10.5005/jp-journals-10071-24129
pmc: PMC9015916
doi:
Types de publication
Journal Article
Langues
eng
Pagination
339-360Informations de copyright
Copyright © 2022; Jaypee Brothers Medical Publishers (P) Ltd.
Déclaration de conflit d'intérêts
Source of support: This work was supported by Deputy for Research of Tabriz University of Medical Sciences. Conflict of interest: None
Références
JPEN J Parenter Enteral Nutr. 2017 May;41(4):530-533
pubmed: 28445681
Front Med (Lausanne). 2018 May 07;5:124
pubmed: 29868585
Crit Care Med. 2009 Oct;37(10):2709-18
pubmed: 19885994
Clin Infect Dis. 2015 May 15;60 Suppl 2:S129-34
pubmed: 25922398
Chest. 2017 Feb;151(2):492-499
pubmed: 27771302
JPEN J Parenter Enteral Nutr. 2016 Feb;40(2):159-211
pubmed: 26773077
Clin Infect Dis. 2015 Jan 1;60(1):64-75
pubmed: 25252684
Am J Clin Nutr. 2010 Mar;91(3):687-703
pubmed: 20089732
J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S58-63
pubmed: 18542041
Cochrane Database Syst Rev. 2016 Oct 20;10:CD004267
pubmed: 27763732
Expert Rev Anti Infect Ther. 2019 Aug;17(8):635-645
pubmed: 31318576
Evid Rep Technol Assess (Full Rep). 2011 Apr;(200):1-645
pubmed: 23126627
JPEN J Parenter Enteral Nutr. 2013 May-Jun;37(3):310-7
pubmed: 23064257
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Brain Behav Immun. 2017 Oct;65:57-67
pubmed: 28606462
Exp Dermatol. 2019 Nov;28(11):1210-1218
pubmed: 31386766
Chest. 2013 Mar;143(3):646-655
pubmed: 23460153
Clin Nutr ESPEN. 2019 Oct;33:220-275
pubmed: 31451265
Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):37
pubmed: 31346841
Am J Respir Crit Care Med. 2015 Jul 1;192(1):57-63
pubmed: 25871807
Crit Care. 2016 Aug 19;19:262
pubmed: 27538711
Medicine (Baltimore). 2019 Jul;98(27):e16068
pubmed: 31277101
F1000Res. 2017 Nov 29;6:2061
pubmed: 29225790
Front Pharmacol. 2017 Oct 09;8:717
pubmed: 29062279
JAMA. 2009 Dec 2;302(21):2323-9
pubmed: 19952319
Am J Respir Crit Care Med. 2010 Oct 15;182(8):1058-64
pubmed: 20522788
Expert Opin Drug Saf. 2014 Feb;13(2):227-39
pubmed: 24405164
BMJ Open. 2020 Jun 21;10(6):e035930
pubmed: 32565465
J Clin Epidemiol. 2016 Jan;69:225-34
pubmed: 26092286
Clin Nutr. 2007 Apr;26(2):182-92
pubmed: 17011083
Chest. 2015 Feb;147(2):347-355
pubmed: 25340476
Crit Care Med. 2012 Dec;40(12):3290-302
pubmed: 22975886
Curr Opin Crit Care. 2017 Apr;23(2):167-174
pubmed: 28092309
Gut Microbes. 2017 Nov 2;8(6):521-543
pubmed: 28640662
Cochrane Database Syst Rev. 2017 Sep 08;9:CD010723
pubmed: 28884476
Sao Paulo Med J. 2017 Nov-Dec;135(6):578-586
pubmed: 29267517
Cochrane Database Syst Rev. 2014 Oct 25;(10):CD009066
pubmed: 25344083
Respir Care. 2020 May;65(5):673-685
pubmed: 32127415
PLoS One. 2013 Dec 18;8(12):e83934
pubmed: 24367620
Int J Nurs Stud. 2020 Jul;107:103582
pubmed: 32380262
Chest. 2012 Oct;142(4):859-868
pubmed: 22797719
J Dig Dis. 2017 Dec;18(12):698-703
pubmed: 29148175
Crit Care. 2011;15(6):R290
pubmed: 22136422
Cochrane Database Syst Rev. 2017 Apr 21;4:CD011384
pubmed: 28431202
Ann Intern Med. 2018 Aug 21;169(4):240-247
pubmed: 30014150
J Res Med Sci. 2014 Sep;19(9):827-33
pubmed: 25535496
Nutr Clin Pract. 2014 Feb;29(1):29-43
pubmed: 24297678
Clin Sci (Lond). 2004 Mar;106(3):287-92
pubmed: 14558885
Crit Care. 2012 Jun 25;16(3):R109
pubmed: 22731894
Intensive Care Med. 2002 Jun;28(6):797-801
pubmed: 12107689
Crit Care Med. 2010 Mar;38(3):954-62
pubmed: 20016381
J Int Med Res. 2019 Nov;47(11):5349-5374
pubmed: 31578896